Lumigan Gets First-Line Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved Allergan's glaucoma therapy Lumigan (bimatoprost ophthalmic solution) for use as a first-line treatment, the agency announced June 22